Official Title
Impact of SARS-CoV-2 Infection on the Incidence of ICU Acquired Colonization Related to Multidrug-resistant Bacteria
Brief Summary

This multicenter before-after study aimed to determine the impact of infection related to SARS-CoV-2 on the incidence of ICU-acquired multidrug resistant (MDR) bacteria.

Detailed Description

Multicenter observational before-after study, aiming to determine the impact of infection
related to SARS-CoV-2 on the incidence of ICU-acquired colonization and infection related to
MDR bacteria.

Completed
SARS-COV2
Critical Illness
Eligibility Criteria

Inclusion Criteria:

- Expected ICU stay > 48 hours

- Rectal and nasal BMR screening performed < 48 hours after admission to ICU

Exclusion Criteria:

- Patients aged < 18 years Refusal to take part in the study ICU-stay < 48 hours At
least a second rectal and nasal BMR screening was not performed prior to ICU discharge
(a posteriori exclusion criterion).

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
France
Locations

Chu Amiens Picardie
Amiens, France

Ch Bethune
Béthune, France

Grand Hopital de L'Est Francilien
Jossigny, France

CH LENS
Lens, France

Hôpital Roger Salengro, ICU, CHU Lille
Lille, France

Hospices Civils de Lyon (Pierre Bénite,Edouard Herriot, La Croix Rousse)
Lyon, France

Hospices Civils de Lyon
Lyon, France

Saad Nseir, MD,PhD, Principal Investigator
University Hospital, Lille

University Hospital, Lille
NCT Number
Keywords
Covid-19
Critically ill patients
multidrug-resistant bacteria
Infection
colonization
MeSH Terms
Critical Illness